L-NDDP

Drug Profile

L-NDDP

Alternative Names: AR 726; Aroplatin; Liposomal NDDP; NDDP; Platar

Latest Information Update: 11 Oct 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Sumitomo Pharma; University of Texas M. D. Anderson Cancer Center
  • Developer Agenus
  • Class Antineoplastics; Platinum complexes
  • Mechanism of Action Alkylating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Colorectal cancer; Non-Hodgkin's lymphoma; Solid tumours

Most Recent Events

  • 24 Sep 2003 Phase II study data have been added to the adverse events and Cancer therapeutic trials sections ,
  • 24 Sep 2003 Antigenics has completed a phase II monotherapy trial in metastatic colorectal cancer patients in the USA
  • 18 Jul 2002 Phase-II clinical trials in Colorectal cancer in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top